Thermo Fisher May Need to Boost Qiagen Bid Again, Investor Says

(Bloomberg) -- Thermo Fisher Scientific Inc. may need to once again sweeten its bid for Qiagen NV since the Dutch biotech’s outlook has improved so much during the pandemic, a second major investor...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.